News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cambria Biosciences Announces Discovery Collaboration With Syngenta (SYT)



10/19/2005 5:09:00 PM

Cambria Biosciences LLC, a drug discovery company, today announced a three-year collaboration with Syngenta Limited, a world leading agribusiness. Cambria will use its technology to elucidate the mechanism of action of small molecule compounds supplied by Syngenta to guide the discovery and development of new classes of safe and effective insecticides. Under the terms of the agreement, Syngenta will provide full research funding and certain in-kind resources to Cambria for this program. Financial terms were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES